Biogen CEO Vounatsos on Drug Pipeline, Pricing

The video features an interview with Biogen's CEO discussing the company's strategic focus on reinvigorating its drug pipeline, particularly in neurology and neuro repair. The CEO emphasizes the importance of both internal innovation and external partnerships. Financial strategies are highlighted, with a focus on solid foundations and careful capital allocation. The discussion also covers pricing strategies, addressing the challenges of price increases and the need for value-based contracting with pharmacy benefit managers.

How does the CEO reconcile the company's stance on price increases with the recent price hike of a drug?

What strategies does the CEO propose to manage pricing in a competitive market?

What changes does the CEO suggest for the relationship with pharmacy benefit managers?